pharmacology of haemostasis and thrombosis Flashcards

1
Q

What happens when the endothelium of a blood vessel is damaged?

A

The underlying collagen is exposed.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What happens when collagen is exposed in a damaged blood vessel?

A

von Willebrand factor (vWF) binds to the exposed collagen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the function of vWF in this process?

A

vWF acts as a molecular bridge between platelets and exposed collagen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How does vWF tether passing platelets to the exposed collagen?

A

vWF binds to a specific complex of glycoproteins on the platelet membrane called the glycoprotein 1b-IX-V complex.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What happens to the binding site on vWF before it is bound to collagen?

A

The binding site on vWF is masked until it is bound to collagen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What happens to the vWF molecule when it is exposed to the shear forces of blood flow past the immobilized vWF?

A

The vWF molecule unwinds and exposes the binding section.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What happens once a platelet is tethered to the exposed collagen via vWF?

A

More vWF-GP1b interactions occur as the platelet rolls with the force of blood flow over the endothelial surface, and lots of immobilized vWF is ready and waiting to bind to GP1b-IX-V complexes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Are the interactions between vWF and the glycoprotein 1b-IX-V complex stable enough to keep platelets tethered on their own?

A

No, these interactions are not stable enough and rely on strengthening and stabilisation by various other interactions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What do the further steps and interactions triggered by the vWF-GP1b-IX-V interactions do?

A

They help to “activate” the platelets.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What do activated platelets do that they wouldn’t normally do when they’re not activated?

A

They start to bind to fibrinogen via their GP2b3a, which is important in facilitating platelet aggregation (clustering).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How does GP2b3a crosslink with other platelets?

A

GP2b3a crosslinks with other platelets via the fibrinogen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What do activated platelets generate from arachidonic acid under the influence of cyclooxygenase?

A

Activated platelets generate thromboxane A2.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What happens to the thromboxane A2 that is generated by activated platelets?

A

Thromboxane A2 is released from the platelet and binds to thromboxane receptors on other platelets.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Is thromboxane A2 an example of an agonist to platelet function?

A

Yes, thromboxane A2 is an example of an agonist to platelet function, meaning it enhances the effects of platelets.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the result of thromboxane A2 binding to its receptors on other platelets?

A

It promotes yet more activation, aggregation, and adhesion of platelets.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are some potential side effects of aspirin?

A

Peptic ulceration, rash, and hearing loss/tinnitus (at high doses). Brain and liver damage have also been observed in children given aspirin for viral illness.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How does aspirin work to reduce inflammation and pain?

A

Aspirin blocks the production of prostaglandins and thromboxanes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the mechanism of action of aspirin?

A

Aspirin irreversibly inhibits Cycloxygenase 1 (COX 1).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How does aspirin’s mechanism of action differ from that of other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) like ibuprofen?

A

Aspirin is an irreversible inhibitor of COX 1, while NSAIDs like ibuprofen are reversible inhibitors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the importance of prostaglandins in the gastric lining’s resistance to acid?

A

The gastric lining’s resistance to acid is prostaglandin dependent.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

How does aspirin affect platelet function?

A

Aspirin works on cyclooxygenase, leading to decreased production of thromboxane. With less thromboxane, there can be less binding to the thromboxane receptor and so less agonistic effect on platelet adhesion, activation, and aggregation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the role of prostacyclin in platelet function, and how does it compare to thromboxane A2?

A

Prostacyclin inhibits platelet aggregation and promotes vasodilation, whereas thromboxane A2 promotes platelet aggregation and vasoconstriction. Prostacyclin is released from normal endothelium under the influence of cyclooxygenase.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

At high doses, how does aspirin affect the production of both thromboxane and prostacyclin?

A

At high doses, the effect of aspirin on COX1 inhibits production of both thromboxane and prostacyclin. This is slightly counterintuitive to what we are trying to achieve, which is inhibition of platelet aggregation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

How can lower doses of aspirin be used to selectively inhibit platelets
while keeping endothelial cell function intact?

A

Using a lower dose of aspirin can selectively inhibit platelets, while keeping endothelial cell function intact.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What is the overall effect of aspirin on platelet function?

A

The overall effect of aspirin is inhibition of activation, aggregation, and adhesion of platelets.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

In which patients is aspirin used?

A

Aspirin is used in all patients with established vascular disease, including those with ischaemic heart disease (myocardial infarction, angina), cerebrovascular disease, and peripheral vascular disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

How does aspirin improve prognosis?

A

Aspirin improves prognosis by reducing mortality and adverse events such as heart attack and stroke.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What is the cost of aspirin compared to other drugs?

A

Aspirin is a mainstay drug and is considered very cheap.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What is the role of ADP in platelet aggregation?

A

Activated platelets release ADP which binds to P2Y12 receptor on other platelets. This enhances the ability of platelets to aggregate, activate and adhere.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What is clopidogrel and why was it developed?

A

Clopidogrel is a platelet P2Y12 receptor inhibitor. It was developed to combat acute coronary stent thrombosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What is the CAPRI trial and what did it find?

A

The CAPRI trial (1996) compared clopidogrel to aspirin in patients with stable arterial disease. The trial found that clopidogrel was more effective with a similar safety profile.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

When is clopidogrel used as part of dual anti-platelet therapy (DAPT)?

A

Clopidogrel is used as part of DAPT in patients post-MI and elective coronary stenting, and in patients with recurrent stroke despite aspirin. It is also first-line therapy for peripheral arterial disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What are the side effects of clopidogrel?

A

Side effects of clopidogrel include bleeding which affects timing of major surgery, and rash.

34
Q

What is clopidogrel resistance and what are the implications of it?

A

Clopidogrel resistance refers to the up to 30% of patients who do not get the full effect of clopidogrel. It increases bleeding in DAPT.

35
Q

What is the mechanism of action of tirofiban?

A

Tirofiban acts as a glycoprotein IIb/IIIa receptor inhibitor, preventing platelet aggregation.

36
Q

In what situations is tirofiban used?

A

Tirofiban is only used in high-risk coronary stent procedures, primary percutaneous coronary intervention for ST-elevation myocardial infarction, and high-risk coronary anatomy.

37
Q

What is the function of the glycoprotein IIb/IIIa receptor?

A

The glycoprotein IIb/IIIa receptor is the final common pathway of platelet aggregation.

38
Q

What are the potential risks associated with tirofiban use?

A

Very powerful anti-thrombotic drugs like tirofiban carry a high bleeding risk.

39
Q

What is the mechanism of action of Warfarin?

A

Warfarin inhibits the production, specifically gamma carboxylation of the vitamin K dependent coag factors- 2,7,9,10. It also inhibits the production of 2 natural anticoagulants protein C and S.

40
Q

What is the therapeutic window for Warfarin and how is it monitored?

A

Warfarin has a narrow therapeutic window and it is monitored by measuring the International Normalized Ratio (INR) which measures the extrinsic clotting pathway. The aim for INR is usually 2-3 in most cases.

41
Q

What are the clinical uses of Warfarin?

A

Warfarin is the drug of choice for patients with mechanical heart valves and mitral stenosis with AF. It is also used for stroke prophylaxis in AF, DVT, and PE.

42
Q

What are the side effects of Warfarin?

A

The side effects of Warfarin include bleeding, slow reversal with Vitamin K, rapid reversal with blood factors, birth defects (teratogenic), and Warfarin-induced skin necrosis. It is also associated with a transient hypercoagulable state on warfarin induction, so there is often an overlap with heparin.

43
Q

What are the 3 natural anticoagulants in the body?

A

Protein C, Protein S, Antithrombin (AT)

44
Q

What is the mechanism of action of heparin?

A

Heparin enhances the effect of antithrombin (AT), which inhibits clotting factors 2, 7, 9, 10, 11, and 12.

45
Q

How is the therapeutic effect of heparin monitored?

A

The therapeutic effect of heparin is measured by the activated partial thromboplastin time (APTT), which tests the intrinsic clotting pathway. The aim is to achieve 1.5-2.5 times the control value.

46
Q

What is the route of administration of heparin?

A

Heparin can be given intravenously or subcutaneously.

47
Q

What is the antidote for heparin?

A

The antidote for heparin is protamine, which is a potent vasodilator.

48
Q

What are the side effects of heparin?

A

The main side effect of heparin is bleeding.

49
Q

What is the difference between unfractionated heparin and low molecular weight heparins?

A

Unfractionated heparin is used in chronic kidney disease, dialysis, bypass machines, etc., while low molecular weight heparins, such as Enoxaparin and Tinzaparin, are given subcutaneously, have reliable absorption, and do not require monitoring.

50
Q

What is the mechanism of action of heparin?

A

Heparin enhances the effect of the natural anticoagulant AT by binding to it and activating it. AT has an inhibitory effect on coagulation factors 2, 7, 9, 10, 11, and 12, most of which are involved in the intrinsic pathway.

51
Q

How is the therapeutic effect of heparin measured?

A

The therapeutic effect of heparin can be measured by the APTTr (activated partial thromboplastin time), which measures the intrinsic pathway of coagulation. The aim is to achieve 1.5-2.5 times the control value.

52
Q

What are the side effects of heparin?

A

The main side effect of heparin is bleeding. However, there is an antidote called Protamine, which is a potent vasodilator.

53
Q

What are the clinical uses of low molecular weight heparins?

A

Low molecular weight heparins are used acutely for MI, AF, PE, iliofemoral DVT, and VTE prophylaxis.

54
Q

What is Heparin-induced thrombocytopenia?

A

A potentially dangerous side-effect of heparin.

55
Q

Is Heparin-induced thrombocytopenia more common with UFH or LMWH?

A

It is more common with UFH (unfractionated heparin).

56
Q

What causes Heparin-induced thrombocytopenia?

A

It is caused by antibodies that bind to complexes of heparin and platelet factor 4 (PF4).

57
Q

What happens when antibodies cause Heparin-induced thrombocytopenia?

A

Antibodies activate the platelets, causing a prothrombotic state.

58
Q

What are the symptoms of Heparin-induced thrombocytopenia?

A

Falling platelet count, extension of a previously diagnosed blood clot, or new blood clot elsewhere (skin necrosis).

59
Q

What are DOACs?

A

DOACs are direct oral anticoagulants.

60
Q

Name some examples of DOACs.

A

Examples of DOACs include Rivaroxaban, Apixaban, and Dabigatran.

61
Q

What is the mechanism of action of Rivaroxaban and Apixaban?

A

Rivaroxaban and Apixaban are Factor 10a inhibitors.

62
Q

What is Dabigatran?

A

Dabigatran is a direct thrombin inhibitor.

63
Q

What are some clinical uses of DOACs?

A

DOACs are used for DVT/PE/AF and post-hip/knee replacement prophylaxis.

64
Q

How do DOACs compare to warfarin in terms of efficacy and bleeding risk?

A

Higher doses of DOACs are more effective with the same bleeding risk, while lower doses are as effective with less bleeding.

65
Q

What is an advantage of DOACs over warfarin in terms of drug interactions?

A

DOACs have fewer drug interactions than warfarin.

66
Q

What is the antidote for Dabigatran?

A

The antidote for Dabigatran is Idarucizumab.

67
Q

What is the antidote for Rivaroxaban and Apixaban?

A

The antidote for Rivaroxaban and Apixaban is Andexanet.

68
Q

What are the historic treatments for haemophilia?

A

Fractionated human plasma.

69
Q

What is used now for the treatment of haemophilia?

A

Recombinant DNA to produce products.

70
Q

What are the infusions used for the treatment of haemophilia?

A

Infusions of recombinant factor VIII or factor IX.

71
Q

What is the prophylaxis for the treatment of haemophilia?

A

Infusions of recombinant factor VIII or factor IX every 2-3 days.

72
Q

What is the treatment of haemophilia when bleeding/injured?

A

Infusions of recombinant factor VIII or factor IX on demand.

73
Q

What is gene therapy used for in the treatment of haemophilia?

A

To introduce a copy of the gene that encodes for the missing clotting factor.

74
Q

What is the treatment for vWD?

A

Desmopressin (DDAVP), anti-fibrinolytics (eg Tranexamic acid), and plasma products.

75
Q

What does Desmopressin (DDAVP) do in the treatment of vWD?

A

Increases synthesis/release of vWF and FVIII.

76
Q

What do anti-fibrinolytics do in the treatment of vWD?

A

Reduce thrombus breakdown.

77
Q

What is the purpose of plasma products in the treatment of vWD?

A

To replace vWF and Factor VIII.

78
Q

What are some conditions that can lead to a deficiency of vitamin K?

A

Fat malabsorption, biliary obstruction (jaundice), haemorrhagic disease of the newborn, and warfarin treatment.

79
Q

What are some vitamin K-dependent factors?

A

Factor X, IX, VII, and II, as well as proteins S and C. A useful mnemonic for remembering these factors is “1972 was the diSCo era.”

80
Q

How is vitamin K used in the treatment of deficiency and warfarin effects?

A

Vitamin K is used to treat vitamin K deficiency and to reverse the effects of warfarin.